In liver ischemic preconditioning (IP), stimulation of adenosine A2a receptors (A2aR) prevents ischemia/reperfusion injury by promoting diacylglycerol-mediated activation of protein kinase C (PKC). By concerting diacylglycerol to phosphatidic acid, diacylglycerol kinases (DGKs) act as terminator of diacylglycerol signalling. This study investigates the role of DGK in the development of hepatocyte IP. DGK activity and cell viability were evaluated in isolated rat hepatocytes preconditioned by 10 min hypoxia followed by 10 min re-oxygenation or by the treatment with the A2aR agonist, CGS21680, and subsequently exposed to prolonged hypoxia. We observed that after IP or A2aR activation, a decrease in DGK activity was associated with the onset of hepatocyte tolerance to hypoxia. CGS21680-induced stimulation of A2aR specifically inhibited DGK isoform h by activating RhoA-GTPase. Consistently, both siRNA-mediated downregulation of DGK h and hepatocyte pretreatment with the DGK inhibitor R59949 induced cell tolerance to hypoxia. The pharmacological inhibition of DGK was associated with the diacylglyceroldependent activation of PKC d and e and of their downstream target p38 MAPK. In conclusion, we unveil a novel signalling pathway contributing to the onset of hepatocyte preconditioning, which through RhoA-GTPase, couples A2aR to the downregulation of DGK. Such an inhibition is essential for the sustained accumulation of diacylglycerol required for triggering PKC-mediated survival signals.
Adenosine production and release by stressed cells has been shown to have an important function in modulating tissue damage and repair.
1 Among these effects, adenosine is regarded as a key mediator in the development of cell tolerance to ischemia and reperfusion injury triggered by ischemic preconditioning (IP). [2] [3] [4] IP has been proposed as a simple procedure to reduce ischemia/reperfusion injury after hepatic resection and orthotopic liver transplantation. 5 However, the application of IP in hepatic surgery is limited by the high interindividual variability of the responses, 6 indicating the need for a better inside in the mechanisms involved.
The importance of adenosine in hepatic preconditioning is supported by the observation that targeted deletion of hepatic ecto-5 0 -nucleotidase blocks adenosine generation during hypoxia and abolishes liver protection by IP. 7 The hepatocyte response to adenosine autocrine loop has been characterized to some extent showing that the stimulation of adenosine A2a receptors (A2aR) is coupled to the combined activation of phosphatidylinositol 3-kinase/Akt pathway and the novel protein kinases C (nPKC), namely, PKCd and PKCe that on their turn lead to the stimulation of a network of protein kinases including p38 MAP kinase (p38 MAPK). 8, 9 The membrane recruitment and activation of PKCd and PKCe is fully dependent on their direct interaction with diacylglycerol generated by A2aR-induced activation of phospholipase C-g, through a mechanism requiring both Src and PI3K activities. 8, 9 These finding are consistent with central role of nPKCs in the development of the protective action of IP in several tissues. [10] [11] [12] An increasing body of evidence suggests that diacylglycerol signalling is also regulated by diacylglycerol kinases (DGKs), which metabolize diacylglycerol to phosphatidic acid. 13 DGKs are a family of enzymes encoded by 10 distinct genes, grouped in five structurally related classes. 13 Accordingly, the genetic ablation of some DGK isoforms results in the deregulated activation of specific diacylglycerol-mediated signalling pathways. 13 These observations suggest that the regulation of DGK activity may provide a strict control of the kinetic as well as of the extent of diacylglycerol signalling. However, direct evidence that extracellular ligands control intracellular diacylglycerol signalling by negative regulating specific DGK isoforms is still missing. Thus, we set to investigate whether negative regulation of a DGK activity might contribute to diacylglycerol-dependent activation of PKCd/e on adenosine-induced hepatic preconditioning.
Results
Hypoxic preconditioning and activation of adenosine receptors negatively regulate DGKh in primary hepatocytes. We first investigated whether preconditioning of rat hepatocytes affected the total DGK activity. Figure 1a shows that hepatocyte preconditioning, obtained by the 10 min exposure to hypoxia followed by 10 min reoxygenation, reduced total DGK activity by about 50%. A similar effect was also induced by hepatocytes treatment with either adenosine (10 mM) or CGS21680 (1 mM), a specific A2aR agonist (Figure 1b and c) . Concomitantly, CGS21680 increased at least two-folds the intracellular diacylglycerol concentration (Figure 1d ). To identify the DGK isoforms putatively regulated by A2aR, DGK expression was investigated in primary hepatocytes by RT-PCR. DGKz, y and d were the most expressed isoforms, whereas DGKa was expressed at low levels and DGKb, g, e, Z and i were not expressed ( Figure 2 ). We obtained no positive signals with several primer pairs for rat DGKk (not shown). As the suppression of DGK-1, the Caenorhabditis elegans orthologue of DGKy, positively regulates diacylglycerol in response to the serotonin receptor stimulation, 14, 15 we set to investigate the regulation of DGKy in response to A2aR activation. The DGKy enzymatic activity measured in immunoprecipitates obtained using two distinct anti-DGKy antibodies raised against different epitopes was significantly reduced on CGS21680 stimulation (Figure 3a and b) , whereas DGKy protein expression was not affected (Figure 3 ). DGKy involvement was further confirmed by the use of a well-characterized anti-DGKy neutralizing antibody 16 that decreased by about 80% the recovered DGKy activity in immunoprecipitates (Figure 3c ). All together, these data indicate that the activation of A2aR provides a signal that negatively regulates DGKy activity, likely contributing to the sustained accumulation of diacylglycerol.
RhoA-dependent inhibition of DGKh mediates A2aR-induced protection of hepatocytes from hypoxiainduced cell death. Biochemical evidence both in neuroblastoma 17 and in C. elegans motoneurons 14 shows that the enzymatic activity of DGKy and of its orthologue DGK-1 is strongly inhibited on direct interaction with the small GTPase RhoA. 18 Thus, we set to investigate the interaction between active RhoA and DGKy in PC12 cells,, a rat cell line expressing A2aR 19, 20 transiently co-transfected with FLAGtagged DGKy and myc-tagged RhoA. Consistently with earlier published data, 18 FLAG-DGKy co-immunoprecipited with constituitvely active myc-RhoA-V14, but not with inactive myc-RhoA-N14 mutants from unstimulated cells (Figure 4) . Moreover, FLAG-DGKy specifically co-precipitated with myc-RhoA in anti-myc immunoprecipitates from CGS21680-stimulated cells, but not from unstimulated cells (Figure 4 ). In the whole, these data confirmed that indeed DGKy is recruited in a complex with active RhoA. We then moved to investigate whether RhoA regulated DGKy activity on A2aR activation in primary rat hepatocytes. To this aim, we first verified whether RhoA was regulated by activation of A2aR. Indeed, on 15 min treatment, CGS21680 increased by 50% RhoA-GTP complex, as measured by pull-down assay with immobilized rothekin-Rho binding domain (Figure 5a and b) . Such A2aR-induced activation of RhoA was insensitive to the addition of pertussis toxin (data not shown). Next, to verify whether DGKy inhibition downstream from A2aR was mediated by RhoA-GTP, primary hepatocytes were treated with the cell permeable analogue of Clostridrium botulinumderived C3 transferase (1 mM), a highly specific RhoA inhibitor stabilizing RhoA in the inactive GDP-bound form. Inhibition of RhoA entirely reverted CGS21680-induced inhibition of DGKy (Figure 5c ), showing that RhoA-GTP mediated the inhibition of DGKy triggered on A2aR activation. Moreover, the inhibition of RhoA by C3 tranferase abolished the protection against hypoxic injury in hepatocyte treated with CGS21680 (Figure 5d ). In the whole, these data showed that the cytoprotective signalling downstream from A2aR requires the activation of RhoA-GTPase followed by the inhibition of DGKy on binding of RhoA to its catalytic site.
To provide further support to the claim that RhoA-mediated inhibition of DGKy contributed to A2aR-dependent signalling in preconditioning, we downregulated the expression of DGKy in HTC cells by specific siRNAs. HTC cells are rat hepatocyte-derived cell lines that, similar to primary hepatocytes, undergoe an A2aR-mediated preconditioning. 21 Downregulation of DGKy expression was obtained by transient transfection of two different specific siRNAs or a control siRNA and verified by western blot 48 h after transfection. As shown in Figure 6a , both anti-DGKy siRNAs specifically downregulated DGKy and not the other major hepatocytes DGK isoforms (DGKa, d and z). On 60 min exposure to hypoxia, un-transfected cells and cells transfected with control siRNA underwent a significant loss of cell viability ( Figure 6b ). Conversely, HTC cells transfected with either of the DGKy-specific siRNAs were fully protected from hypoxic damage, as were the cells pretreated with CGS21680 ( Figure 6b ). Thus, these data show that specific downregulation of DGKy isoform in HTC cells provides a sufficient signalling to induce tolerance to hypoxic damage.
Pharmacological inhibition of DGK is sufficient to activate signals leading to hepatocyte resistance to hypoxic damage. To identify the key role played by the negative regulation of DGKy in mediating adenosine-induced preconditioning, led us investigate whether direct modulation of diacylglycerol turnover through pharmacological inhibition of DGK could induce hepatocytes resistance to hypoxic damage. The DGK inhibitor R59949 is known to preferentially inhibit DGKa, b, g and d isoforms, 22 whereas DGKz, one of the major DGK isoforms expressed in hepatocytes, is resistant to R59949 22 and no information is available on the R59949 sensitivity to other DGK isoforms. Herein, we show that R59949 at 10 mM, but not at lower concentrations, effectively inhibited hepatocyte DGKy activity as assayed 'in vitro' in anti-DGKy immunoprecipitates ( Figure 7a ). Accordingly, in the same cells, 10 mM R59949 induced a sustained increase in intracellular diacylglycerol concentration ( Figure 7b ). Pretreatment with R59949 also protected primary hepatocytes from hypoxia-induced cell death (Figure 7c ), whereas it did not affect viability of control cells. Moreover, in primary hepatocytes as well as in HTC cells, R59949 increased PKCd and PKCe activities in both membrane and cytosolic fractions (Figure 8a ). The extent of both diacylglycerol accumulation ( Figure 7b ) and enzymatic activation of PKCd and PKCe was highly similar to that induced by CGS21680-mediated activation of A2aR (Figure 8a ). Moreover, neither pharmacological inhibition of DGK nor A2aR stimulation promoted the enzymatic activities of PKCa, b1 and b2, which are regulated by both calcium and diacylglycerol ( Figure 8a ). We showed earlier that PKCd/edependent phosphorylation of p38 MAPK is required for A2aR-induced protection from hypoxic damage. 7 Consistently, R59949-mediated inhibition of DGK stimulated the dual phosphorylation Thr 180 / Tyr 182 of p38 MAPK (Figure 8b ). The effect induced by DGK inhibition was comparable to that obtained by the activation of A2aR and was prevented by the PKC inhibitor chelerythrine (50 mM) (Figure 8b) . Moreover, the inhibition of either PKC or p38 MAPK kinase with, respectively, chelerythrine or SB203580 (5 mM) abolished R59949-induced protective effects against hypoxic hepatocyte death (Figure 7c ). All together, these findings indicate that the pharmacological inhibition of DGK provides sufficient diacylglycerol accumulation to trigger PKCmediated signals leading to resistance to hypoxic damage.
Discussion
It is increasingly clear that the development of IP in many tissues, including the liver, requires the activation of a complex network of signals comprising cell-surface receptors, redox signals and diverse arrays of protein kinases such as reperfusion injury salvage kinases that rapidly re-modulate several cell functions to better cope with energy loss, oxidative stress and ion unbalances associated with hypoxia and reperfusion. 3, 4, 10, 23, 24 Among these protein kinases, PKCd and PKCe have a key function by coupling adenosine receptors to downstream stress-activated protein kinases Erk1/2 and p38 MAPKs. 3, 4, 24 Moreover, translocation of PKCe to the mitochondria has been implicated in preventing mitochondrial permeability transition on myocardial reperfusion. 25 PKCd and PKCe membrane recruitment and activation are fully dependent on their direct interaction with diacylglycerol, generated by adenosine-induced activation of phospholipase C-g and diacylglycerol analogues fully mimic the activation of the signals that onset IP. 8, 9, 26 However, the accumulation of cellular diacylglycerol is dependent also on the rate of its rapid metabolism to phosphatidic acid by DGKs. 13 Recent data indicate that the genetic deletion of specific DGK isoforms results in a sustained diacylglycerol signalling in different cell systems and tissues. 13 Moreover, the role of DGKs as the terminator of diacylglycerol-mediated signals has been recently underscored by the finding that several DGK isoforms are recruited to the activated muscarinic receptors, in which they rapidly metabolize diacylglycerol similarly to the action of phosphodiesterase towards cAMP. 27 However, so far, no direct biochemical evidence is available for a receptor-mediated negative regulation of any DGK isoform. In this study, we show that in hepatocytes both hypoxic preconditioning and A2aR stimulation lead to a strong decrease in total DGK activity that contributes to diacylglycerol accumulation. In particular, we show that enzymatic activity Figure 4 The adenosineA2a receptor agonist CGS21680 promotes DGKy association with RhoA/C GTPase. DGKy/RhoA association was evaluated in PC12 cells transfected with FLAG-DGKy and either with wild-type myc-RhoA (wt) or constitutive active myc-RhoA-V14 (active) or inactive myc-RhoA-N19 (inactive) mutants. After trasfection, cells were serum starved for 24 h and treated with CGS21680 for 30 min. Cells were then lysed and transfection verified by western blotting and protein association was assessed after immunoprecipitation with antimyc-specific antibodies using western blotting with anti-FLAG-specific antibodies of DGKy, that is, along DGKz the most abundant isoform in hepatocytes, is strongly inhibited on A2aR activation. This provides the first demonstration of a negative regulation of a DGK isoform by extracellular ligands. However, we cannot rule out that other DGK isoforms beside DGKy may be inhibited on hepatocyte A2aR activation. Nevertheless, the demonstration that specific genetic downregulation of DGKy expression is sufficient to protect HTC hepatoma cells from hypoxic damage, indicates that the negative regulation of the DGKy isoform may be sufficient to trigger the onset of cytoprotective signals on A2aR activation by hypoxic preconditioning.
The localization and function of DGKy have been reported earlier to be regulated by several G-protein coupled receptors, although the molecular mechanisms underlying such a regulation have not been fully investigated. For instance, in vascular smooth muscle cells purinergic receptors promote PKC-mediated recruitment of DGKy to the plasma membrane, whereas norepinephrine stimulates DGKy activity at lipid rafts. [28] [29] [30] [31] Herein, we show that on ligand stimulation of A2aR, RhoA is activated, binds and inhibits DGKy . Such an Rho-A signalling is required for A2aR-induced inhibition of DGKy as well as for the development of cytoprotection. These findings are consistent with the evidence that both DGKy and its C. elegans orthologue, DGK-1 are inhibited on the direct binding of active RhoA to their catalytic domain. 18, 32 Moreover, in motoneurons of C. elegans, the activation of the RhoA orthologue, Rho-1, leads to diacylglcyerol accumulation, which then allows the recruitment and activation of PKC-1 and UNC-13 proteins. 33 Thus, our finding that in hepatocytes RhoA-mediated inhibition of DGKy triggers cytoprotective signalling downstream from A2a receptors, unveils the general relevance of a novel Rho-mediated signalling pathway linking G-protein coupled receptors to the negative regulation of DGKy activity. Such a novel pathway is conserved from C. elegans to different mammalian tissues and may enable G-protein coupled receptors to regulate the extent and the kinetics of diacylglycerol-mediated signalling, by finetuning the enzymatic activity of DGKy. This is also the first evidence for a direct activation of RhoA by A2aR, albeit in hepatic stellate cells A2aR has been reported recently to mediate RhoA inhibition through the cAMP-mediated activation of protein kinase A. 34 It is known that G-protein coupled receptors activate RhoA-GTPases, by coupling the pertussis toxin insensitive Ga12/13 or Gaq/11 proteins to, respectively, p115 or Trio RhoGEFs. 35 Moreover, previous evidence indicates that A2aR couples to Ga12/13 in endothelial cells. 36 On the other hand, A2aR-induced activation of hepatocyte RhoA is pertussis toxin insensitive, suggesting that it may be mediated through either Ga12/13 or Gaq/11 37 and ruling out the involvement of inhibitory G (Gai)-proteins, which instead transduce A2aR-induced Src-mediated signalling to PI3-kinase and PLC-g. 9 These findings indicate that A2aRs by interacting with, respectively, Gai or Ga12/13(q/11) In some experiments, cells were pretreated with the PKC inhibitor cheletrytrine (50 mM). The relative intensity of phosphorylated and non-phosphorylated bands was measured by videodensitometry and the results were expressed as ratios after normalization at one of the controls. A representative experiment is shown together with the quantification of five independent experiments. Statistical significance: *Po0.005 versus control or cells treated with R59940 þ cheletrytrine or CGS21680 þ cheletrytrine GTPases promote both the PLC-g-mediated diacylglycerol synthesis and, at the same time, inhibit diacylglycerol catabolism by DGK (Figure 9) . Thus, the accumulation of diacylglycerol required for preconditioning-induced PKCd/e activation results from the fine-tuning of the enzymes responsible for both diacylglycerol generation and catabolism. Such an interpretation is consistent with a growing body of evidence suggesting that the temporal and spatial regulation of intracellular second messengers depends on the simultaneous reciprocal regulation of both activating and de-activating enzymes, such as adenylate cyclase and phosphodiesterase for cAMP, and PI3-kinase and PTEN for PI(3,4,5)P3. 38, 39 Moreover, these observations underscore the relevance of negative regulators for the transduction of the complex signals required for the onset of the cytoprotective machinery in IP. In this latter respect, a decline in the activity of PTEN is evident in parallel with PI3K activation during brain and myocardium preconditioning. 40, 41 By unveiling that the RhoA-mediated-negative regulation of DGKy is essential for A2aR-dependent hepatocyte preconditioning, these results suggest that the pharmacological inhibition of DGK may likely trigger cytoprotection. Indeed, the treatment of primary hepatocytes with the DGK inhibitor R59949 is sufficient to induce adequate diacylglycerol accumulation to activate diacylglycerol-dependent nPKCs, fully protecting hepatocytes from hypoxic damage. On pharmacological inhibition of DGK, adequate diacylglycerol levels likely build from the unstimulated basal phospholipids turnover, even in absence of a receptor-mediated activation of PLC-g. At the concentrations used in this study, R59949 inhibits several DGK isoforms including DGKy, DGKd and DGKa, but does not affect DGKz, which is along with DGKy the most abundant DGK isoform expressed in hepatocytes. Thus, the inhibition of DGKy may be largely responsible for R59949-induced protection, although we cannot rule out the involvement of other DGKs, such as DGKd and DGKa.
In conclusion, the data presented characterize a novel signalling pathway in the mechanisms by which adenosine promotes hepatic preconditioning involving DGKy downregulation. These findings indicate DGK modulation as a potential target of new pharmacological strategies aimed to induce tolerance to ischemia/reperfusion injury in organs such as the liver, the myocardium and the kidney, which relay on nPCK activity for the development of the cytoprotective effects of preconditioning.
Materials and Methods
Hepatocyte preparation and treatments. Primary hepatocytes were isolated by collagenase (Sigma, Milan, Italy) liver perfusion of fed male Wistar rats (180-250 g weight) (Harlan, San Pietro al Natisone, Udine, Italy). 8 The use and care of the animals were approved by the Italian Ministry of Health. Hepatocytes were suspended in Krebs-Henseleit-Hepes medium (final cell density of 10 6 /ml) and preconditioned by exposure to 10 min of hypoxia (95% N 2 -5% CO 2 ) followed by 10 min re-oxygenation (95% air-5% CO 2 ) or by 15 min treatment with CGS21680 (Sigma) as described earlier. 8 Hypoxic damage was evaluated by exposing hepatocytes to 90 min hypoxia immediately after preconditioning procedures. Control cells were maintained under normoxic atmosphere (95% air-5% CO 2 ). The inhibitors SB203580, chelerythrine (Sigma) and the cell-permeable C. boltulinumderived C3 transferase (Citoskeleton, Denver, CO, USA) were added, respectively, 5, 15 and 120 min before preconditioning. R59949 (Sigma) was added 15 min before hypoxic exposure.
Cell cultures and treatments. HTC rat hepatoma cell line was obtained from the European Collection of Cell Cultures and cultured in DMEM-HAM F12 medium containing 10% foetal calf serum and 1% penicillin/streptomycin, 1% glutamine. The preconditioning procedures and treatments were the same as those used for primary hepatocytes. PC12 cell line was kind gift from Prof. C Isidoro (University of East Piedmont, Novara, Italy). Cells were cultured on collagen-coated dishes in RPMI medium containing 15% foetal calf serum and 1% penicillin/ streptomicin, 1% glutamine. PC12 cells were transfected using lipofectamine (Invitrogen, San Giuliano, Milan, Italy) with either FLAG-tagged DGKy and the myctagged forms of wild-type RhoA or constitutively active mutant V14-RhoA or inactive mutant RhoA-N19
18,32 using. FLAG-DGKy/myc-RhoA association was evaluated in 10 6 transfected PC12 cells serum starved for 24 h and treated with CGS21680 for 30 min. After treatments, the cells were lysed and immunoprecipitated with antimyc-specific antibodies (Santa Crutz Biotechnologies, Santa Crutz, CA, USA) and protein G Sepharose beads. The immunoprecipitates were analysed with anti-FLAG-specific antibodies (Sigma).
Assay of total and isoform-specific DGK activity. For total DGK assay, 10 6 hepatocytes were homogenated in 1 ml of a buffer containing 25 mM Hepes pH 8, 10% glycerol, 150 mM NaCl, 5 mM EDTA, 2 mM EGTA, 1 mM ZnCl 2 , 50 mM ammonium molibdate, 10 mM NaF, 1 mM sodium orthovanadate and Sigma Figure 9 Proposed role of DGKy inhibition and phospholypase C activation in the recruitment of protein PKC-dependent survival pathways responsible for inducing the resistance to hypoxia of preconditioned hepatocytes. During hepatocytes preconditioning, adenosine A2 receptor (A2aR) stimulation induces RhoA/C activation and an RhoA/C-dependent inhibition of DGKy activity. The consequent decrease in diacylglycerol (DAG) metabolism to phosphatidic acid (PA) allows a stable increase in DAG intracellular level that maintains the activation of the DAG-dependent cytoprotective signals protease inhibitor cocktail and spinned at 500 Â g for 15 min. The enzyme activity was assayed in 25 ml of the homogenate by measuring phosphatidic acid formation during 5 min incubation at 301C in the presence of 1 mg/ml diolein, 5 mM ATP, 3 mCi/ml [g32P]-ATP (GE Healthcare, Cologno Monzese, Milan, Italy), 10 mM MgCl 2 , 1 mM ZnCl 2 , 1 mM EGTA in 25 mM Hepes pH 8, final reaction volume 50 ml. Reaction was stopped with 200 ml of 1 M HCl and lipids were extracted with 200 ml chloroform/methanol (1 : 1). Phosphatidic acid was separated by thin layer chromatography (TLC) in chloroform/methanol/water/25% ammonium hydroxide (60 : 47 : 11 : 4) using TLC plates coated earlier with potassium oxalate 1.3%, EDTA 5 mM/methanol (3 : 2) and desiccated.
[g32P]-phosphatidic acid formation was identified by comigration with non-radioactive phosphatidic acid formation standards stained by exposure to iodine vapours. Radioactive signals were detected and quantified by GS-250 Molecular Imager and Phosphor Analyst Software (Bio-Rad, Milan, Italy).
The specific DGKy activity was evaluated by the same method after DGKy immunoprecipitation with protein A Sepharose and two anti-DGKy-specific antibodies recognizing different DGKy epitopes (Santa Cruz Biotechnologies) according to Houssa et al. 18 DGKy western blotting was performed using 25 mg of hepatocyte proteins and a specific anti-DGKy antibody (BD Biosciences, San Jose, CA, USA) . To verify the effects of neutralizing antibodies on DGK activity, control IgG (Santa Cruz Biotechnologies, Milan, Italy) and anti-DGKy inhibitory IgG (50 mg/ ml; BD Biosciences) were added to the samples 30 min before the assay. The results were acquired and quantified with GS-250 Molecular Imager and Phosphor Analyst Software (Bio-Rad).
RhoA/C-GTP pull-down assay. RhoA/C-GTP pull-down assays were performed according to Ren et al. 42 Briefly, 10 6 hepatocytes were washed in icecold PBS and lysed with 1 ml GST-fish buffer (50 mM Tris-HCl, pH 7.2, 1% Triton X-100, 5% sodium deoxicolate, 0.1% SDS, 500 mM NaCl, 10 mM MgCl2, supplemented with fresh 1 mM Na 3 VO4, protease inhibitors, and 1 mM dithiothreitol); 5% of each sample was directly denatured in Laemmli buffer for whole cell lysate proteins analysis. The remaining clarified lysates were incubated for 60 min with purified GST6-Rhotekin-RBD at 41C, pre-coupled to GlutathioneSepharose beads (GE Healthcare, Cologno Monzese, Milan, Italy). After four washes with 1 ml of Tris buffer (1% Triton X-100, 150 mM NaCl, 10 mM MgCl 2 , protease inhibitors) samples were re-suspended in Laemmli buffer, heat denatured and separated by SDS-PAGE in a 12% polyacrylamide gel. RhoA/C was visualized by western blotting and quantified using Versadoc with Quantity One software (BioRad). RhoA/C activation was calculated as GTP-Rho ratio to Rho in total cell lysate.
RT-PCR determination of rat DGK isoforms. RNA was extracted from 10 6 hepatocytes or HTC cells using charge switch total RNA cell kit (Invitrogen, San Giuliano, MI, Italy). Reference RNA was extracted from 200 mg rat brain using Tri reagent (Applied Biosystems, Austin, TX, USA). RNA aliquots (200 ng) were retrotranscribed using the RT kit (Applied Biosystems, Austin, TX, USA). One-tenth of the cDNA obtained was amplified using Go-Taq Master Mix (Promega, Milan, Italy AUGUUAAUGAAGAUAAGACdTdT. An siRNA with no matching sequences in the rat genome (Ambion, Austin, TX, USA) was used as negative control. HTC cells were transfected using Lipofectamine 2000 (Invitrogen) according to manufacturer recommendations. Transfection efficiency was analysed after 72 h using BLOCK-iT Fluorescent Oligo (Invitrogen) procedure according to the producer instruction The transfection efficiency of HTC cells with the different siRNAs was more than 75%.
Diacylglycerol quantification. Hepatocyte content of diacylglycerol was evaluated in the lipids extracted from 2 Â 10 6 hepatocytes as described by Bligh and Dyer. 43 Briefly, hepatocyte content of diacylglycerol was evaluated by extracting 2 Â 10 6 hepatocyte pellets with 0.750 ml CHCl 3 /CH 3 OH (1 : 2 v/v) and the phases were separated by the addition of 0.25 ml CHCl 3 and 0.25 ml H 2 O followed by centrifugation at 1000 Â g for 5 min. The lower phase was dried, re-dissolved in 50 ml CHCl3 and spotted on a silica 60 TLC plate (Sigma). Diacylglycerol was eluted with diethylether/heptane/acetic acid (75 : 25 : 1 v : v : v) mixture, the plates were dried and stained with 0.003% Coomassie brilliant blue in 30% CH 3 OH and 100 mM NaCl for 30 min. The plates were de-stained for 5 min in dyefree solution and the bands were acquired with Versadoc system. The band density was calculated with Quantity One software (Bio-Rad). The amount of diacylglycerol was calculated using a standard curve of dioleyl-diacylglycerol (Sigma).
Assay of PKCs activities. PKC isoforms were immunoprecipitated with rabbit polyclonal a, b, b1, d and e anti-antibodies (Santa Cruz Biotechnology) and protein A Sepharose. After three washes in a buffer containing 10 mmol/l Tris-HCl, 150 mmol/l NaCl, 10 mmol/l MgCl 2 and 0.5 mmol/l dithiotreitol, PKC activity was assayed by using 10 g of histone H1 as substrate and a reaction mixture containing 0.1 mmol/l ATP, 2 mCi/sample[32P]ATP (GE Healthcare), 1 g of phophatidylserine and 0.4 mg of diacylglycerol as reported earlier. 8 Analysis of p38 MAPK phosphorylation state. The phosphorylation state of p38 MAPK was assessed by using dual (Thr 180 /Tyr 182 ) phosphorylated p38 MAPK and total p38 MAPK antibodies (PhosphoPlus p38 MAPK antibody kit, New England BioLabs, Beverly, MA, USA).
Determination of cell viability. Cell viability was estimated by microscope counting the hepatocyte excluding Trypan blue and by the determination of nuclear fluorescence staining with propidium iodide. 8 Data analysis and statistical calculations. The data were expressed as mean ± S.D or ± S.E.M. Statistical analysis was performed by Instat 3 statistical software (GraphPad Software Inc., San Diego, CA, USA) using one-way ANOVA test with Bonferroni's correction for multiple comparisons when more than two groups were analysed. Distribution normality of all groups was preliminary verified by Kolmogorov and Smirnov test. Significance was taken at 5% level.
Conflict of interest
The authors declare no conflict of interest.
